menu ☰
menu ˟

Tofacitinib plus methotrexate sustain improvements for 2 years in RA

25 Mar 2019
A twice daily 5-mg or 10-mg dose of tofacitinib plus methotrexate was associated with improved clinical and radiographic responses between 1 and 2 years among patients with rheumatoid arthritis, with no new safety signals, according to findings publi...

Click here to view the full article which appeared in Rheumatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.